uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted December 26, 2008

Generic Manufacturer Suspends Production of All Tablets -- Including Generic Metoprolol Succinate ER

On December 23, 2008, KV Pharmaceutical advised the FDA that it voluntarily suspended all shipments of all of its FDA approved drug products in tablet form, including Metoprolol Succinate ER 100 mg and 200 mg products. [See related Drug Investigation of Metoprolol Succinate ER. Also see 8/28/2008 posting below for FDA Warning Letter regarding generic Metoprolol Succinate ER made by another manufacturer].

KV did not recall products on the market other than a single lot of its hydromorphone HCl 2mg tablets.

A news release stated that KV was taking this action to review and enhance the company's manufacturing and quality systems. The company was unable to determine when distribution would resume. A list of all affected products is available.